Table 3.

Cancer Risk in Patients With Schizophrenia by Gender

Cancer Site/Type	Male			Female
	O	SIR	95% CI	O	SIR	95% CI
Upper aerodigestive tract	78	0.48	0.38–0.60	31	0.58	0.39–0.83
Salivary gland	5	0.47	0.15–1.11	7	0.73	0.29–1.51
Esophagus	30	0.52	0.35–0.75	19	0.92	0.55–1.43
Stomach	106	0.56	0.46–0.68	78	0.63	0.50–0.79
Small intestine	13	0.70	0.37–1.20	21	1.29	0.80–1.98
Colon	180	0.71	0.61–0.83	246	0.83	0.73–0.94
Rectum	100	0.59	0.48–0.72	100	0.74	0.60–0.90
Anus	7	1.21	0.48–2.51	15	1.27	0.71–2.09
Liver	78	0.71	0.56–0.89	110	0.91	0.75–1.09
Pancreas	76	0.69	0.55–0.87	67	0.65	0.50–0.82
Nose	8	0.91	0.39–1.81	2	0.35	0.03–1.28
Lung	270	0.67	0.60–0.76	181	0.91	0.78–1.05
Breast	10	1.62	0.77–3.00	1315	1.24	1.17–1.31
Cervix	0			133	0.84	0.71–1.00
Endometrium	0			311	1.34	1.20–1.50
Ovary	0			177	0.85	0.73–0.98
Other female genital	0			34	0.93	0.64–1.30
Prostate	412	0.45	0.41–0.50	0
Testis	49	0.94	0.69–1.24	0
Other male genital	16	1.05	0.60–1.72	0
Kidney	116	0.89	0.73–1.06	61	0.64	0.49–0.83
Urinary bladder	148	0.61	0.51–0.71	61	0.67	0.51–0.87
Melanoma	72	0.64	0.50–0.80	89	0.70	0.57–0.87
Skin, squamous cell	90	0.59	0.47–0.73	78	0.66	0.52–0.83
Nervous system	107	0.86	0.71–1.04	97	0.74	0.60–0.91
Thyroid gland	11	0.54	0.27–0.97	36	0.75	0.52–1.03
Endocrine glands	37	0.86	0.60–1.18	98	1.07	0.87–1.31
Bone	7	0.67	0.27–1.40	7	1.08	0.43–2.23
Connective tissue	23	0.79	0.50–1.18	21	0.85	0.53–1.31
Non-Hodgkin lymphoma	124	0.74	0.62–0.89	95	0.74	0.60–0.91
Hodgkin's disease	27	0.94	0.62–1.37	11	0.62	0.31–1.11
Myeloma	36	0.69	0.48–0.96	34	0.71	0.49–0.99
Leukemia	61	0.75	0.58–0.97	40	0.57	0.41–0.77
Cancer of unknown primary	98	0.83	0.67–1.01	121	0.85	0.71–1.02
All	2405	0.63	0.61–0.66	3732	0.94	0.91–0.97

Note: Abbreviations are explained in the first footnote to table 2.